Specialty & Oncology May 2019

Febrile neutropenia is a medical emergency that requires immediate evaluation and empirical antibiotics. 

The frequent occurrence of mutations and gene alterations has spurred the development of novel agents for the treatment of AML, including new oral targeted therapies that have recently received regulatory approval.